Oncology Institute (DFPH) Return on Invested Capital (2021 - 2022)
Oncology Institute's (DFPH) quarterly Return on Invested Capital came in at 3.99% in Q3 2022, up 402.0% YoY from 0.8% in Q3 2021, and up 8.31% on a QoQ basis from 3.69% in Q2 2022.
Oncology Institute (DFPH) Return on Invested Capital (2021 - 2022) Analysis & Trends
Oncology Institute (DFPH) has 2 years of Return on Invested Capital data on file, last reported at 3.99% in Q3 2022.
- Quarterly Return on Invested Capital rose 402.0% year-over-year to 3.99% in Q3 2022, while the trailing twelve-month figure through Sep 2022 was 3.99% (up 402.0% YoY) and the FY2021 annual result came in at 0.16%, changed N/A from the prior year.
- Return on Invested Capital grew to 3.99% in Q3 2022, from 3.69% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 3.99% in Q3 2022 to a low of 3.7% in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 0.00% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 0.00% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 0.00% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 0.04% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 0.21% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | -0.04% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 0.02% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 0.06% |
| 10 | Oncology Institute | 201.94 Mn | 160.85 Mn | 27.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 3.99% |
| Jun 30, 2022 | 3.69% |
| Mar 31, 2022 | -3.70% |
| Dec 31, 2021 | -0.16% |
| Sep 30, 2021 | -0.03% |
| Jun 30, 2021 | -0.02% |